ArticleAdvances in therapy2023

Cost-Effectiveness of Brentuximab Vedotin Versus Physician's Choice of Methotrexate or Bexarotene for the Treatment of Cutaneous T-cell Lymphoma in Canada.

David Elsea et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.